<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37774212</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1842-1121</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of gastrointestinal and liver diseases : JGLD</Title><ISOAbbreviation>J Gastrointestin Liver Dis</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Sacral Nerve Stimulation in Non-constipated Irritable Bowel Syndrome Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>384</StartPage><EndPage>392</EndPage><MedlinePgn>384-392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15403/jgld-4801</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS">Irritable bowel syndrome (IBS) is a prevalent disorder with a complex and heterogeneous physiopathology, including a dysregulation of gut-brain axis. Treatment for IBS is targeted to the predominant symptom and requires a multidisciplinary approach. This review aims to evaluate the efficacy and safety of sacral nerve stimulation in non-constipated IBS patients Methods: A literature search was carried out on MEDLINE, The Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science databases for all relevant articles. Quality of included papers was assessed using standardized guidelines Results: Of 129 initial citations, 7 articles met our predefined inclusion criteria, including five randomized trials, a pilot study and a descriptive follow-up study. Five of 7 studies reported a positive effect of sacral nerve stimulation on symptoms and quality of life improvement in non-constipated IBS patients. No study reported serious adverse events.</AbstractText><AbstractText Label="CONCLUSIONS">Despite initial promising results of sacral nerve stimulation in non-constipated IBS patients, studies with larger sample sizes and longer follow-up are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia-Cabrera</LastName><ForeName>Ana Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. anam.gcabrera@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De la Portilla</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. delaportilla@ucpsevilla.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Rodr&#xed;guez</LastName><ForeName>Rosa Mar&#xed;a</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. ros_j_r@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Monchul</LastName><ForeName>Jorge Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. jmvmco@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-D&#xed;az</LastName><ForeName>Mar&#xed;a Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. milu_1983@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramallo-Sol&#xed;s</LastName><ForeName>Irene Mar&#xed;a</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. irene.ramallo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pintor-Tortolero</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. jose.pintor.tortolero@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dios-Barbeito</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. sandra_dios89@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padillo-Ruiz</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Virgen del Roc&#xed;o University Hospital, Seville, Spain. javierpadilloruiz@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Romania</Country><MedlineTA>J Gastrointestin Liver Dis</MedlineTA><NlmUniqueID>101272825</NlmUniqueID><ISSNLinking>1841-8724</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>15</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774212</ArticleId><ArticleId IdType="doi">10.15403/jgld-4801</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>